We randomly assigned @ patients with Child-Pugh class A cirrhosis to receive either @ or @ weeks of treatment with ABT-@ / r-ombitasvir ( at a once-daily dose of @ mg of ABT-@ , @ mg of ritonavir , and @ mg of ombitasvir ) , dasabuvir ( @ mg twice daily ) , and ribavirin administered according to body weight .